STUDY OBJECTIVE: Determine the sensitivity and specificity of [F-18]-fluorine-2-deoxy-D-glucose positron emission tomography (FDG-PET) in differentiating non-small cell lung cancer (NSCLC) from benign solitary pulmonary nodules (SPNs) in a region with a high endemic rate of histoplamosis. DESIGN: Prospective, clinical study. SETTING: University, tertiary referral hospital in the upper Mississippi River valley. PATIENTS: Ninety patients with SPNs. INTERVENTIONS: Independent interpretation of FDG-PET imaging, computed tomography and pathologic evaluation of the SPNs. MEASUREMENTS AND RESULTS: To detect malignant SPNs, FDG-PET imaging had a sensitivity of 93%, a specificity of 40%, a positive predictive value (PPV) of 88% and a negative predictive value (NPV) of 55%. CONCLUSIONS: In a region with a high prevalence of pulmonary fungal infection, FDG-PET is sensitive but has a low specificity and NPV for identifying NSCLC. In our study cohort, FDG-PET does not appear to reduce the need for SPN biopsies.
STUDY OBJECTIVE: Determine the sensitivity and specificity of [F-18]-fluorine-2-deoxy-D-glucose positron emission tomography (FDG-PET) in differentiating non-small cell lung cancer (NSCLC) from benign solitary pulmonary nodules (SPNs) in a region with a high endemic rate of histoplamosis. DESIGN: Prospective, clinical study. SETTING: University, tertiary referral hospital in the upper Mississippi River valley. PATIENTS: Ninety patients with SPNs. INTERVENTIONS: Independent interpretation of FDG-PET imaging, computed tomography and pathologic evaluation of the SPNs. MEASUREMENTS AND RESULTS: To detect malignant SPNs, FDG-PET imaging had a sensitivity of 93%, a specificity of 40%, a positive predictive value (PPV) of 88% and a negative predictive value (NPV) of 55%. CONCLUSIONS: In a region with a high prevalence of pulmonary fungal infection, FDG-PET is sensitive but has a low specificity and NPV for identifying NSCLC. In our study cohort, FDG-PET does not appear to reduce the need for SPN biopsies.
Authors: Lukas B Been; Albert J H Suurmeijer; David C P Cobben; Pieter L Jager; Harald J Hoekstra; Philip H Elsinga Journal: Eur J Nucl Med Mol Imaging Date: 2004-12 Impact factor: 9.236
Authors: Stephen Deppen; Joe B Putnam; Gabriela Andrade; Theodore Speroff; Jonathan C Nesbitt; Eric S Lambright; Pierre P Massion; Ron Walker; Eric L Grogan Journal: Ann Thorac Surg Date: 2011-05-18 Impact factor: 4.330
Authors: Eric L Grogan; Stephen A Deppen; Karla V Ballman; Gabriela M Andrade; Francys C Verdial; Melinda C Aldrich; Chiu L Chen; Paul A Decker; David H Harpole; Robert J Cerfolio; Robert J Keenan; David R Jones; Thomas A D'Amico; Joseph B Shrager; Bryan F Meyers; Joe B Putnam Journal: Ann Thorac Surg Date: 2014-02-25 Impact factor: 4.330
Authors: Rianot Amzat; Pooneh Taleghani; Daniel L Miller; Jonathan J Beitler; Leah M Bellamy; Jonathon A Nye; Weiping Yu; Bital Savir-Baruch; Adeboye O Osunkoya; Zhengjia Chen; William F Auffermann; Mark M Goodman; David M Schuster Journal: Mol Imaging Biol Date: 2013-10 Impact factor: 3.488
Authors: Stephen A Deppen; Jeffrey D Blume; Clark D Kensinger; Ashley M Morgan; Melinda C Aldrich; Pierre P Massion; Ronald C Walker; Melissa L McPheeters; Joe B Putnam; Eric L Grogan Journal: JAMA Date: 2014-09-24 Impact factor: 56.272
Authors: Stephen A Deppen; Pierre P Massion; Jeffrey Blume; Ronald C Walker; Sanja Antic; Heidi Chen; Michele M Durkin; L Joseph Wheat; Eric L Grogan Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-10-19 Impact factor: 4.254